Jefferies Group LLC Kezar Life Sciences, Inc. Transaction History

Jefferies Group LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Sep 21, 2023	SELL	$4.58 - $17.13 $184,116 - $688,626	-40,200 Reduced 80.08%	10,000 $82,000
Q2 2022 Aug 15, 2022	BUY	$4.58 - $17.13 $45,800 - $171,300	10,000 New	10,000 $83,000
Q1 2022 May 16, 2022	SELL	$12.3 - $18.33 $617,460 - $920,165	-50,200 Closed	0 $0
Q4 2021 Sep 21, 2023	BUY	$7.44 - $16.72 $373,488 - $839,344	50,200 New	50,200 $839,000
Q4 2021 Feb 14, 2022	BUY	$7.44 - $16.72 $373,488 - $839,344	50,200 New	50,200 $839,000
Q3 2020 Nov 13, 2020	SELL	$4.36 - $5.5 $2.18 Million - $2.75 Million	-500,400 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$3.6 - $7.75 $1.8 Million - $3.88 Million	500,400 New	500,400 $2.59 Million

38.4M

13.8K

600

Ticker KZR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 68,369,504
Market Cap $446M
Description
Kezar Life Sciences, Inc., a clinical-stage biotechnology company, engages in the discovery and development of novel small molecule therapeutics to treat unmet needs in immune-mediated diseases and cancer in the United States. The company's lead product candidate is KZR-616, a selective immunoproteasome inhibitor that is in Phase 2 clinical tria...

Get notified when there are updates to the investment portfolio of Jefferies Group LLC, based on Form 13F filings with the SEC.

Stay updated on Jefferies Group LLC with notifications on news.